The world is changing fast for medical device companies and it’s becoming an evolve or die moment for big companies and small ones. In this month’s MedCity News Google Hangout, I will be talking with four people who working on new and innovative devices. Each person’s work is designed to help patients or make treatment […]
Everyone likes to talk about funding for digital health – Y Combinator is doing biotech now! Andreesen Horowitz gets into health tech! Deals and dollars look great in Q1 2014! It’s not as easy to make cheery slide decks about funding for the rest of the healthcare startup world: pharma, medical devices and bio tech […]
Everyone likes to talk about funding for digital health – Y Combinator is doing biotech now! Andreesen Horowitz gets into health tech! Deals and dollars look great in Q1 2014! It’s not as easy to make cheery slide decks about funding for the rest of the healthcare startup world: pharma, medical devices and bio tech […]
It’s your turn to join the 250 investors, entrepreneurs and other healthcare leaders at today’s MidAmerica Healthcare Venture Forum. More than a half-dozen authorities on crowdfunding in healthcare will take part in a panel session, “Crowdfunding and the Jobs Act in Healthcare” starting at 10:10 a.m. Central Time. The session is a series of one-on-one […]
Welcome to MedCity News’ March hangout on how move with digital health into the mainstream, with a focus on wearables in healthcare, where we’re talking with entrepreneurs working to bring digital health to the rest of us: doctors running their own practices, pharmacists working to improve medical adherence, people living with chronic conditions and companies […]
At a conference in San Diego this month, a keynote speaker asked how many people in the audience were wearing a fitness tracker. About a dozen people raised their hands. “It’s always the healthiest people you know who are wearing a FitBit,” GreatCall CEO David Inns said. “That’s not going to do anything to cut […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
I have a great job because every day I get to talk to smart people doing interesting work to make healthcare better. In February’s MedCity News Hangout, I spoke with four of those people about big data. The conversation included a designer, a neuroscientist, an expert in consumer payments and a doctor. Each person brought […]
Today is our February Hangout and we’ll be talking about entrepreneurs who are wrangling big streams of data into manageable intelligence. We also will have a doctor in on the conversation to have a provider-centric reality check in place. Scroll down to see examples of a blood test result from WellnessFX. Tweet your questions to […]
It’s time to hang out again. This month I’ll be talking with entrepreneurs who are wrangling big streams of data into manageable intelligence. We also will have a doctor in on the conversation to have a provider-centric reality check in place. You can join the conversation on the MedCity News Google + page or right […]
The hype from CES 2014 has faded, but wearable tech has not lost any of its momentum. So far this year, we’ve learned that 1.5 million trackers have shipped in six months and that Apple is becoming a heart doctor. If the four sensor experts I spoke to at the end of January are right, […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
